What Is the Contribution of Intraoperative Radiotherapy (IORT) in Tailoring Local Therapy in Primary or Recurrent Rectal Cancer?
Combined modality therapy, preferably preoperative chemoradiation and radical surgery, is the standard of care for local treatment in patients with locally advanced rectal cancer. Local pelvic control is expected superior to 85% at 5 years. Intraoperative radiotherapy (IORT) is a high-quality radiation-boosting technique for dose-escalation purposes in limited anatomic regions considered at risk at the time of surgical resection. In-field IORT recurrence rates are inferior to 5% in primary disease. The experience available using IORT as a component of treatment, both in primary and localized recurrent disease, is updated. Factors associated to topographic (in-field control/recurrence) pelvic results are discussed to potentially guide a tailored use of IORT according to local risk estimations.
- 8.Roeder F, Treiber M, Oertel S et al (2007) Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 67:1381CrossRefPubMedGoogle Scholar
- 18.Calvo FA, Sole CV, Alvarez de Sierra P et al (2013) Prognostic impact of external beam radiation therapy in patients treated with and without extended surgery and intraoperative electrons for locally recurrent rectal cancer: 16-year experience in a single institution. Int J Radiat Oncol Biol Phys 86:892–900CrossRefPubMedGoogle Scholar